🔎 Trials Near Me

Početna › Rak dojke › Florida

Kliničke studije za Rak dojke u državi Florida

146 studija za Rak dojke traži sudionike na lokacijama u državi Florida.

Gradovi u državi Florida

Službeni tekst studije (engleski)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
  • Advent Health, Orlando
  • Florida Cancer Specialists South, Port Charlotte
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04585750

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Holy Cross Health, Fort Lauderdale
  • Memorial Cancer Institute, Hollywood
  • Jupiter Medical Center, Jupiter
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
  • Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
  • Morton Plant Hospital, Clearwater
  • i još 11
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06760819

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

  • Holy Cross Hospital, Fort Lauderdale
  • The Oncology Institute, Lakeland
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07102381

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06625775

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

  • Mayo Clinic in Florida, Jacksonville
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
Od 18 do 45 godina · Žene · Ažurirano 1. lis 2026. · NCT05557877

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

  • Mayo Clinic Florida, Jacksonville
  • Cancer Specialists of North Florida, Jacksonville
  • Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06369285

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Helios CR Inc, Lakeland
  • H. Lee Moffitt Cancer Center and Research Institute, Tampa
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06324357

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

  • University of Florida Proton Therapy Institute, Jacksonville
  • Dwoskin Proton Therapy Center, Miami
  • Miami Cancer Institute, Miami
U tijeku regrutacijaFaza 3
Od 19 godina i više · Žene · Ažurirano 29. ruj 2026. · NCT05856773

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Jacksonville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT05877599

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

  • Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07578571

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Sarasota
  • Avenzo Therapeutics Recruiting Site, Tampa
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT05867251

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0024), Altamonte Springs
  • Comprehensive Hematology Oncology ( Site 0060), St. Petersburg
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07060807

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

  • Baptist MD Anderson Cancer Center, Jacksonville
U tijeku regrutacija
Od 30 godina i više · Žene · Ažurirano 25. ruj 2026. · NCT02945579

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs
  • Florida Cancer Specialists - South ( Site 7004), Fort Myers
  • Bioresearch Partner ( Site 0072), Hialeah
  • i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06966700

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

  • AdventHealth Altamonte Springs ( Site 0021), Altamonte Springs
  • Orlando Health Cancer Institute ( Site 0011), Orlando
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06312176

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

  • Miami Cancer Institute, Miami
  • Miami Cancer Institute, Plantation
U tijeku regrutacijaFaza 3
Od 60 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06377852

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

  • Research Site, Altamonte Springs
  • Research Site, Miami
  • Research Site, Plantation
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06103864

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

  • Morton Plant Hospital - Baycare Health System, Clearwater
  • Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05528133

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • Mayo Clinic, Jacksonville
  • Sylvester Comprehensive Cancer Center, Miami
  • Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07007559

A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

  • D&H National Research Centers INC (Investigational Site number USA-002), Margate
  • United Medical Research (Investigational Site number USA-005), Port Orange
U tijeku regrutacijaFaza 1
Od 18 do 80 godina · Žene · Ažurirano 23. ruj 2026. · NCT07401381

Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)

  • University of Miami, Coral Gables
U tijeku regrutacija
Od 50 godina i više · Žene · Ažurirano 23. ruj 2026. · NCT07502352

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06618287

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

  • Clinical Trial Site, Tampa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Baptist MD Anderson, Jacksonville
  • Mayo Clinic Florida, Jacksonville
  • Jupiter Medical Cancer, Jupiter
  • i još 2
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07214532

Precise Oncology Interventions in Nutrition and Training (OnPoint)

  • University of Miami, Miami
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06534918

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • AdventHealth Altamonte Springs, Altamonte Springs
  • Clermont Oncology Center, Clermont
  • Florida Oncology & Hematology, Fort Myers
  • i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07174336

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Moffitt, Tampa
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07114601

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

  • AdventHealth Altamonte Springs, Altamonte Springs
  • Mayo Clinic in Florida, Jacksonville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Žene · Ažurirano 22. ruj 2026. · NCT07287098

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Moffitt, Tampa
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07213791

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

  • Florida Cancer Specialists, Sarasota
U tijeku regrutacijaFaza 1
Od 18 godina i više · Žene · Ažurirano 21. ruj 2026. · NCT07524855

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

  • TopLine MD Alliance, Miami
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 30 do 74 godina · Žene · Ažurirano 21. ruj 2026. · NCT02620852

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

  • Baptist Alliance Miami Cancer Institute, Miami
U tijeku regrutacijaFaza 2
Od 45 godina i više · Žene · Ažurirano 21. ruj 2026. · NCT04084730

Identifying Patterns in the Breath of Individuals With Breast Cancer

  • Mayo Clinic Breast Clinic, Jacksonville
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 74 godina · Žene · Ažurirano 18. ruj 2026. · NCT06512350

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

  • Florida Cancer Specialists, Fort Myers
  • Cancer Care Centers of Brevard, Inc, Palm Bay
  • Sacred Heart Medical Oncology Group, Pensacola
  • i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07173751

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Florida Cancer Specialists - Lake Nona, Orlando
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07109726

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.